Jane Street Group, LLC Bio N Tech Se Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$126.25 - $231.85 $22.9 Million - $42.1 Million	-181,500 Reduced 38.24%	293,100 $50 Million
Q4 2021 Feb 15, 2022	SELL	$216.64 - $362.52 $27.9 Million - $46.7 Million	-128,800 Reduced 21.35%	474,600 $122 Million
Q3 2021 Nov 16, 2021	BUY	$205.93 - $447.23 $57.8 Million - $126 Million	280,800 Added 87.04%	603,400 $165 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $18.6 Million - $39.6 Million	163,800 Added 103.15%	322,600 $72.2 Million
Q1 2021 May 18, 2021	SELL	$85.73 - $119.5 $15.8 Million - $22 Million	-183,900 Reduced 53.66%	158,800 $17.3 Million

Q4 2020 Feb 17, 2021	BUY	$72.71 - $129.54 $1.45 Million - $2.58 Million	19,900 Added 6.16%	342,700 $27.9 Million
Q3 2020 Nov 17, 2020	BUY	$57.81 - $104.17 $16 Million - $28.8 Million	276,400 Added 595.69%	322,800 $22.1 Million
Q2 2020 Aug 17, 2020	BUY	$38.58 - $66.74 $1.79 Million - $3.1 Million	46,400 New	46,400 $3.11 Million

327

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.